BioCentury
ARTICLE | Company News

Management tracks

May 6, 2015 1:15 AM UTC

Oncology company Cleveland BioLabs Inc. (NASDAQ:CBLI) named Langdon Miller president and CMO. Miller was VP of clinical research in oncology at Gilead Sciences Inc. (NASDAQ:GILD) after it acquired Calistoga Pharmaceuticals Inc., where he had been EVP of R&D.

Cardiovascular play Omeicos Therapeutics GmbH (Berlin, Germany) named Ulrich Dauer CEO. Dauer was chief strategy officer for Activaero GmbH, which was acquired by Vectura Group plc (LSE:VEC). ...